Search

everythinglearnresearchcommunity

for

Search:↓

Treat hair loss with medicine, continue indefinitely.

Women with PCOS have higher cardiometabolic risks.

Diffuse alopecia in females is often linked to certain medications, diseases, and low hemoglobin, while female pattern hair loss is linked to age, duration, and family history.

Low serum ferritin is linked to hair loss in women.

Electrical stimulation with a low-calorie diet reduces appetite, weight, and blood pressure in obese people with sleep apnea.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

Resistance training improved BMI and menstrual regularity more in women with PCOS than aerobic training.

Vitamin D is crucial for skin health and managing skin diseases.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

The document concludes that scalp conditions have various causes and can present in many different ways.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Women with PCOS often have irregular periods, a higher chance of infertility and miscarriages, and may improve fertility with lifestyle changes and treatment.

Obesity negatively affects the endometrium, leading to higher miscarriage risk and impaired cell function.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

Cosmeceuticals may benefit skin health but need more research for efficacy and safety confirmation.

Rodent models of PCOS show some hormone changes similar to humans, but also have key differences.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Caucasian women's hair appears thickest in their 20s, with perceived thinning after mid-30s due to both decreasing density and diameter.

Core symptoms in breast cancer chemotherapy remain stable, aiding targeted interventions.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

Many survivors of critical illness, especially those with sepsis, experience hair loss.